TP53 and cancer: More importantly, this study for the first time indicates that Gb3‐cSrc complex in GEMs elevates the expression of missense mutant p53 R273H not only in mutation‐heterozygous cancer cells, but also in mutation‐homozygous ones (WiDr cells).